Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03502525
Other study ID # GCO 15-1445
Secondary ID 5DP1DA039542-05
Status Recruiting
Phase N/A
First received
Last updated
Start date August 31, 2016
Est. completion date June 2021

Study information

Verified date February 2020
Source New York University
Contact David M. Barnes, PhD
Phone 212-992-3729
Email barned05@nyu.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Break the Cycle is a two-session, one-on-one, in-person intervention study designed to reduce the role persons who inject drugs (PWID) play initiating non-PWID into injection drug use. Study implementation is at two sites: New York City and Tallinn, Estonia. At baseline, quantitative data are collected via a structured computer-assisted personal interview, after which the intervention is conducted. At the 6-month follow-up, a modified version of the interview is repeated. The study uses a pre- versus post- design to compare the proportion of participants who helped with first injections, and who promoted injecting among non-PWID, in the 6 months prior to baseline with the proportions at the 6-month follow-up. Based on previous research on the intervention and on the underlying theory of motivational interviewing, increases in helping and promoting behaviors between baseline and follow-up would indicate that the intervention was not effective regardless of their effect size. Accordingly, the hypotheses that the intervention will produce reductions in assisting with first injections and engaging in injection promoting behaviors will be evaluated using one-tailed statistical tests. Break the Cycle intervention follows a motivational interviewing approach to enhance current injectors' motivation and skills to avoid helping with and promoting first injections among non-PWID. The intervention's core is a discussion between an interventionist and each participant on the following eight topics: the participant's first time injecting drugs; the participant's exposures to situations where helping with others' first injections is an option, and the extent to which they have helped; PWIDs' behaviors that might encourage non-PWID to inject for the first time; the range of risks associated with injection drug use; role-playing scenarios in which the participant develops behaviors and scripts for avoiding or refusing requests to initiate others into injection drug use; role- playing talking with other PWID about not encouraging non-PWID to start injecting; imparting safer injection practices when helping with a first injection seems like the best option; and receiving training in and using Narcan to reverse overdoses.


Recruitment information / eligibility

Status Recruiting
Enrollment 400
Est. completion date June 2021
Est. primary completion date June 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- have injected drugs non-medically in the last 2 months

- able to provide informed consent

- age 18 or older

- able to participate in the interview and intervention in English (in New York City), Russian or Estonian (in Tallinn, Estonia)

Exclusion Criteria:

- none

Study Design


Intervention

Behavioral:
Break the Cycle Intervention
The intervention uses motivational interviewing to enhance persons who inject drugs' (PWID) motivation and skills to avoid helping non-PWID transition to injecting. The intervention entails discussions with participants in 8 areas: the participant's first time injecting; the participant's exposures to situations where helping with non-PWIDs' first injections is an option, and the extent to which they helped; their behaviors that might encourage non-PWID to inject for the first time; the risks associated with injection drug use; role-playing in which participants develop behaviors and scripts for avoiding or refusing requests to initiate non-PWID into injection; role- playing talking with other PWID about not encouraging non-PWID to start injecting; imparting safer injection practices when helping with a first injection seems like the best option; and receiving training in and using naloxone to reverse overdoses.

Locations

Country Name City State
Estonia University of Tartu Tallinn
United States New York University New York New York

Sponsors (3)

Lead Sponsor Collaborator
New York University National Institute on Drug Abuse (NIDA), University of Tartu

Countries where clinical trial is conducted

United States,  Estonia, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of participants helping with first injections Number of participants who helped persons who do not inject drugs with a first injection 6 months
Secondary Number of participants who say positive things Number of participants who saying positive things about injecting to persons who do not inject drugs 6 months
Secondary Number of participants injecting in front of other people Number of participants injecting in front of people who do not inject drugs 6 months
Secondary Number of participants offering to give first injection Number of participants offering to give a first injection to persons who do not inject drugs 6 months
See also
  Status Clinical Trial Phase
Completed NCT00726557 - Post-marketing Surveillance Study of Ex-intravenous Drug Abusers With Chronic Hepatitis C Treated With PegIntron Plus Rebetol (P04408/MK-4031-261) N/A
Completed NCT02487745 - The Long-Term Treatment of Drug Addiction and Unemployment N/A
Completed NCT04556552 - Non-Invasive Vagal Nerve Stimulation in Opioid Use Disorders Phase 3
Completed NCT03093415 - Hepatitis C Treatment in PWIDs: MAT or Syringe Exchange Assisted-therapy vs Standard of Care Phase 4
Completed NCT02797990 - Conflict Between Maternal Autonomy and Child Health in Substance-use N/A
Completed NCT01031745 - Contingency Management in the Delivery of HAART to Drug Users in Chennai, India Phase 2
Completed NCT02774954 - Change the Cycle: An RCT to Prevent Injection Initiation N/A
Completed NCT00471042 - Study of Buprenorphine Maintenance Treatment for Opioid Dependence in Primary Care
Completed NCT02796027 - BRIDGE: Improving HIV Service Delivery for People Who Inject Drugs N/A
Completed NCT00149669 - Employment-based Reinforcement of Naltrexone Ingestion and Abstinence N/A
Completed NCT00244374 - A Randomized Trial of Vaccine Adherence in Young Injection Drug Users N/A
Completed NCT00023283 - Counseling Conditions for Buprenorphine in a Primary Care Clinic - 1 Phase 2
Completed NCT00249470 - The Therapeutic Workplace Initiation Study N/A